Varian Medical Systems, Inc. (VAR): Price and Financial Metrics
GET POWR RATINGS... FREE!
VAR Price/Volume Stats
| Current price | $177.07 | 52-week high | $177.38 |
| Prev. close | $177.11 | 52-week low | $103.67 |
| Day low | $177.03 | Volume | 536,200 |
| Day high | $177.20 | Avg. volume | 746,779 |
| 50-day MA | $176.32 | Dividend yield | N/A |
| 200-day MA | $168.64 | Market Cap | 16.26B |
VAR Stock Price Chart Interactive Chart >
Varian Medical Systems, Inc. (VAR) Company Bio
Varian Medical Systems designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions in the United States. The company operates in two segments, Oncology Systems and Imaging Components. The company was founded in 1948 and is based in Palo Alto, California.
Latest VAR News From Around the Web
Below are the latest news stories about Varian Medical Systems Inc that investors may wish to consider to help them evaluate VAR as an investment opportunity.
Lattice Semi, Progyny, Domtar shoot higher on S&P index movesStocks are on the move after hours following the most recent changes from S&P Dow Jones Indices, starting with PTC. Currently a constituent of the S&P MidCap 400, PTC will move into the S&P 500 to replace Varian Medical Systems (VAR), which was acquired today by Siemens Healthineers. Moving into... |
PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20: |
Varian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive YearVarian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices Industry Data and After-Sales Service Survey for the fourth year in a row. Varian's Net Promoter Score improved by 7.3 percentage points from 2019 to 2020. |
Varian (VAR) Inks Deal With Google Cloud to Boost Cancer CareVarian (VAR) partners with Google Cloud to help in the fight against cancer through the development of an advanced AI based diagnostic platform. |
Varian and Google Cloud Collaborate to Aid in the Fight Against CancerVarian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform to aid in the fight against cancer. Varian and Google Cloud AI embarked on a deployment journey, using Neural Architecture Search (NAS) technology via Google Cloud AI Platform, to create AI models for organ segmentation—a crucial and labor-intensive step in radiation oncology that can be a bottleneck in the cancer treatment clinical workflow. |
VAR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 45.87% |
| 5-year | 49.11% |
| YTD | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 23.24% |
| 2019 | 25.33% |
| 2018 | 1.94% |
Continue Researching VAR
Want to do more research on Varian Medical Systems Inc's stock and its price? Try the links below:Varian Medical Systems Inc (VAR) Stock Price | Nasdaq
Varian Medical Systems Inc (VAR) Stock Quote, History and News - Yahoo Finance
Varian Medical Systems Inc (VAR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...